RP-HPLC Method Development and Validation for Estimation of Isoniazid and Rifampicin in Tablet Dosage Form. by Yelle, Sudheer Kumar
RP- HPLC METHOD DEVELOPMENT AND VALIDATION FOR
ESTIMATION OF ISONIAZID AND RIFAMPICIN IN TABLET
DOSAGE FORM
Dissertation
Submitted to
The Tamilnadu  Dr. M. G. R. Medical University,
CHENNAI
In partial fulfilment for the award of the degree of
MASTER OF PHARMACY
IN
PHARMACEUTICAL ANALYSIS
DEPARTMENT OF PHARMACEUTICAL ANALYSIS
K. M. COLLEGE OF PHARMACY
MELUR ROAD, UTHANGUDI
MADURAI - 625107
APRIL -2014
CERTIFICATE
This  is  to  certify  that  the  dissertation  entitled  “RP-HPLC  METHOD
DEVELOPMENT AND  VALIDATION  FOR  ESTIMATION  OF ISONIAZID  AND
RIFAMPICIN  IN  TABLET DOSAGE  FORM”  submitted by  Mr. YELLE SUDHEER
KUMAR  (Reg.  No:  261230055)  in  partial  fulfilment  of  the  degree  of  Master  of
Pharmacy  in  Pharmaceutical  analysis  under  The  Tamilnadu  Dr.M.G.R  Medical
University, Chennai, done at    K. M. COLLEGE OF PHARMACY, MADURAI - 625107,
is a bonafide work carried out by him under my guidance and supervision during the academic
year April - 2013-2014. The dissertation partially or fully has not been submitted for any other
degree or diploma of this university or other universities.
 GUIDE& HOD PRINCIPAL
Dr. M. Sundarapandian, M. Pharm., Ph.D.,  Dr.S. Venkataraman, M.Pharm., Ph.D.,
Professor and Head,                                   Professor and Head,
Dept. of  Pharmaceutical Analysis, Dept. of  Pharmaceutical Chemistry,  
K.M.College of Pharmacy, K.M.College of Pharmacy,                             
Uthangudi, Madurai-625107, Uthangudi, Madurai-625107,
Tamilnadu. Tamilnadu.
CERTIFICATE
This  is  to  certify  that  the  dissertation  entitled  “RP-HPLC  METHOD
DEVELOPMENT AND  VALIDATION  FOR  ESTIMATION  OF ISONIAZID  AND
RIFAMPICIN  IN  TABLET DOSAGE  FORM”  submitted by  Mr. YELLE SUDHEER
KUMAR  (Reg.  No:  261230055)  K.  M.  COLLEGE  OF PHARMACY,  MADURAI  -
625107, in partial  fulfilment of the University rules and regulations for award of  Master of
Pharmacy in  Pharmaceutical  Analysis  under  my  guidance  and  supervision  during  the
academic year APRIL  2013-2014.
                   HOD                                                         PRINCIPAL
Dr.M. Sundarapandian, M. Pharm., Ph.D.,  Dr. S. Venkataraman, M.Pharm., Ph.D.,
Professor  and  Head,                                   Professor and Head,
Dept. of Pharmaceutical Analysis, Dept. of Pharmaceutical Chemistry,  
K.M.College of Pharmacy, K.M.College of Pharmacy,                             
Uthangudi, Madurai-625107, Uthangudi, Madurai-625107,
Tamilnadu. Tamilnadu.
AN EXPRESION OF GRATITUDE
“With God All Things Are Possible”
Milestones  in  life  are  achieved,  not  by  individual  efforts  but  by  blessings  and
guidance of elders, near and dear one of collective wisdom and experience of all those who
have shared their views far this project is the product beyond those found within the covers of
book. I therefore take this opportunity to express my acknowledgements to all of them.
Let me first thank almighty for giving me life and my parents for educating me and
keeping my requirements in priority at all situations. Without their unconditional support and
encouragement it would have been impossible to pursue my interest.
It gives me immense pleasure to express my deepest thanks, heartfelt, indebtness and
regards  to  my respected  guide,  Dr.  M.SUNDARAPANDIAN.,M.Pharm.,Ph.D., professor
and  HOD., Dept.  of  Pharmaceutical  Analysis,  K.M.College  of  Pharmacy,  Madurai,  for
providing much of the stimuli in the form of suggestions, guidance and encouragements at all
stages of my work.
I  owe  my  great  debt  of  gratitude  and  heartfelt  thanks  to  Prof.  M.  Nagarajan.,
M.Pharm.,M.B.A.,  DMS  (IM).,  DMS  (BM).,chairman,  K.M.College  of  Pharmacy,  Madurai  for
providing me all the facilities and support for the successful completion of my thesis work.
I  express  my  deep  sincere  thanks  to  Dr.  S.  Venkataraman,M.Pharm.,  Ph.D.,Principal,
professor  and  H.O.D,  Dept.  of  Pharmaceutical  chemistry,  for  his  timely  instigation  and
immeasurable esteemed help to complete this thesis.
I  express  my  deep  sense  of  gratitude  and  profound  thankfulness  to  Prof.
M.S.Prakash.,M. Pharm.,  Dept. of Pharmaceutical Analysis, K.M.College of Pharmacy, and
Madurai for his invaluable advice, suggestion and encouragement extended throughout the
work. 
I  submit  sincere  thanks  and  respectful  regards  Mr.T.SRINIVAS  REDDY,
DIRECTOR, AND MY COLLUGES  who provided me all the facilities and his excellent
guidance for my project  and I  am also very thankful  to  staff  of  industry for  their  kind
cooperation.
I extend my thanks to  M. Shanthi.,  B.A, M.Li.Sc., Librarian and  Mrs. M. Sasi kala.,
D.pharm.,  Lab Assistant and  Mrs. J.Sridevi.,  lab attender and all other non-teaching staff
members of our college for their co-operation.
I  cannot  forget  to  express  my  gratitude  and  grateful  thanks  to  my  classmates
Ch.Narayana Swamy,  Chaitu,  Gopi,  Sandhya,  Sasi  ruba and  veeraiah  who  helped  me
directly and indirectly for the successful completion of my project work.
.
                                                                                                    Y. SUDHEER KUMAR
CONTENTS
CHAPTER NO NAME OF THE CHAPTER PAGE NO
                                     ABBREVATIONS
1. INTRODUCTION                                                  01-23
2. DRUG PROFILE 24-25
3. LITERATURE REVIEW                                       26-30
4. AIM AND PLAN OF WORK     31
5.                                 MATERIALS AND INSTRUMENTS                  32-33
6. METHOD DEVELOPMENT 34-39
7. METHOD VALIDATION     40-68
8. RESULTS AND DISCUSSION                              69-70
9. CONCLUSION                       71
BIBLIOGRAPHY
ERRATA
            Introduction to analytical chemistry
1. INTRODUCTION
1.1 Introduction to analytical chemistry(1)
 The pharmaceutical  analysis defined as “the branch of  practical  chemistry
which  deals  with  the  resolution,  separation,  identification,  determination  and
purification  of  a  given  sample  of  a  medicine,  the  detection  and  estimation  of
impurities, which may be present in drug substance (or) given sample of medicine”. 
The substance may be a single compound or a mixture of compounds and may
be in the form a tablet, pill, capsule, ampoule, liquid, mixture or an ointment.
The quality control tests involve methods which embrace chemicals, physio –
chemical, instrumental, microbiological (or) biological procedures.
The  pharmaceutical  analysis  deals  with  the  subject  of  determining  the
composition of material in terms of the elements or compound (drug) present in the
system.
Any type of analysis involves two steps
Identification (qualitative)
Estimation (quantitative)
In qualitative analysis, a reaction is performed in such a way as to indicate the
formation  of  a  precipitate,  a  change  of  a  colour,  the  dissolution  of  a  precipitate
complex formation and the evaluation of a gas.
Quantitative  analysis  is  performed  ordinarily  through  five  steps.  They  are
sampling, dissolution, precipitation, measurement and calculation. 
Analytical Techniques(2, 3,4)
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1) Titrimetricmethods
a) Acid – Base titrations
b) Redox titrations
c) Precipitation  titrations 
d) Non-aqeous titrations
e) Diazotisation titrations
2) Gravimetricmethods
a)Weighing of drug after extraction.
b) Weighing of derivative after separation.
c) Weighing residue after ignition.
3)  Spectrophotometric Methods
a) Colourimetric method
b) Ultra violet method
c) Fluorimetric method
d) Flame photometry
e) Atomic absorption spectroscopy.
f) Infrared spectrophotometry
g) Raman spectroscopy
h) X-ray spectroscopy
i) Mass spectroscopy
4) Electro analytical methods
a) Potentiometry
b) Voltametry
            c) Amperometry
                        d) Electrogravimetry
            e) Conductometry
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f) Polarography 
5) Chromatographic methods
a) Thin layer chromatography
b) Paper chromatography
c) Column chromatography
d) Gas chromatography
e) High Performance Liquid Chromatography
6) Hyphenated techniques
    a) GC-MS (Gas chromatography – Mass spectrometry)
    b) LC-MS (Liquid chromatography – Mass spectrometry)
    c) GC-IR (Gas chromatography – Infrared spectroscopy)
    d) ICP-MS (Inductively coupled plasma – Mass spectrometry)
7) Miscellaneous methods
a) Thermal analysis
b) Kinetic techniques
c) Enzyme assay
d) Microbiological procedure
e) Biological procedure
DIFFERENT  INSTRUMENTAL  METHODS  WITH  BASIC
PRINCIPLES
Table No: 1 Different instrumental methods with principles
Sr. N0. METHOD BASIC PRINCIPLE
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A ELECTROANALYTICAL METHODS
1 Potentiometry
Concerned  with  change  in  electrical
properties of the system measures the change
in  electrode  potential  during  a  chemical
reaction of the system
2 Conductometry Measures  the  change  in  electrical
conductivity during a chemical reaction
3 Polarography
Measures  the  current  at  various  applied
potential  indicating  the  polarization  at
indicator electrode
4 Amperometry Measures the change (or decrease) in current
at a fixed potential during addition of titrant
B SPECTROSCOPIC METHODS
1
Absorption  spectroscopy
(Ultraviolet  –  visible  and
infrared)
Measures  the  absorbance  or  percent
transmittance  during  the  interaction  of
monochromatic  radiation  (or  particular
wavelength) by the same
2 Fluorimetry
Measures  the  intensity  of  fluorescence
caused  by  emission  of  electromagnetic
radiation due to absorption of UV radiation
3 Flame Photometry
Measures  the  intensity  of  emitted  light  of
particular wave length emitted by particular
element
4 Turbidimetry Measures  the  turbidity  of  a  system  bypassing light beam in a turbid media
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Sr. N0. METHOD BASIC PRINCIPLE
5 Nephlometry
Measures the opalescence of the medium
by  reflection  of  light  by  a  colloidal
solution
6
Atomic Absorption 
Spectroscopy
Measures the intensity of absorption when
atoms  absorbs  the  monochromatic
radiation
7 X-Ray Spectroscopy
Measures  the  position  and  intensity  of
spectral  lines  during  emission  of  X-ray
spectrum by atoms under influence of X-
rays
8 Refractometry
Measures the refractive index by causing
refraction of light by matter
9 Polarimetry
Measures optical reaction by causing the
rotation of plane polarized light
C Mass Spectroscopy
Observe  the  position  and  intensity  of
signals in mass spectrum by causing the
ionization of molecules
D NMR Spectroscopy
Observe the position and intensity lines in
NMR spectrum when proton interact with
electromagnetic  radiation  in  radio
frequency region
E Thermal Methods
Measures  the physical  parameters  of  the
system  as  a  function  of  temperature.  It
includes  thermo  gravimetry,  derivative
gravimetry  and  differential  thermal
analysis
F Radiometric Methods
Measure  the  radioactivity  either  present
naturally or induced artificially
PHASES IN ANALYTICAL CHEMISTRY(5)
Phase 1: Fast screening phase eg: Immuno assay, gas chromatography and
          Liquid chromatography.
Phase      2: Identification phase eg: GC – MS.
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Phase       3: Qualification phase eg: Spectrophotometer and gas chromatography.
IMPORTANT CONSIDERATIONS IN ANALYTICAL METHODS(6)
The instrument is the most visible and exciting element of the analytical method
and it is only one component of the total analysis.
• The analyst  should determine the nature of the sample,  the end use of the
analytical results, the species to be analyzed. 
• Quantitative information may include elemental composition, oxidation state,
functional  groups,  major  components,  minor  components,  complete
identification in the given sample.
• Quantitative data include accuracy, precision and range of expected analyte. 
• Methods such as controlling the atmosphere to which the sample is exposed,
controlling  the  temperature  of  the  sample,  buffering  the  pH  of  sample
solutions.
SENSITIVITY AND DETECTION LIMITS (7)
Table No: 2 Sensitivity and detection limits
TECHNIQUES DETECTION LIMITS
IDENTIFICATION
LIMITS
Gas chromatography
Infrared spectrophotometry
Ultraviolet spectroscopy
N.M.R(time averaged)
Mass spectrometry            
(batch inlet)
Mass spectrometry         
(direct probe )
10-6-1012
10-7
10-7
10-7
10-6
10-12
-
10-6
10-6
10-5
10-5
10-11
Factors Affecting the Choice of Analytical Methods(8)
 The type of analysis required.
 Problem arising from the nature of the material.
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 Possible  interference  from components  of  the  material  other  than  those  of
interest.
 The concentration range which needs to be investigated.
 The accuracy required.
 The facilities available.
 The time required for complete analysis.
 Similar type of analysis performed. 
1.2   CHROMATOGRAPHY
Chromatography is a technique in which solutes are resolved by differential rates of
elution  as  they pass  through a  chromatographic  column.  Chromatography is  essentially  a
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group of techniques for the separation of the compounds of mixtures by their continuous
distribution between two phases, one of which moves relative to the other. [4]
History: 
Many  publications  have  discussed  or  detailed  the  history  and  development  of
chromatography.  Table  No.2 lists  the  chronological  order  of  the events  that  are  the most
notable  in  the  development  of  the  present  state  of  the  field.  Since  the  various  types  of
chromatography  (liquid,  gas,  paper,  thin-layer,  ion  exchange,  supercritical  fluid,  and
electrophoresis) have many features in common, they must all be considered in development
of the field. [9]
Table No: 3 Development of the chromatography
Year Scientist Research findings
1834 Runge .F.F
Used  unglazed  paper  and  /  or  pieces  of
cloth for spot testing dye mixtures and plant
extracts
1850 Runge .F.F Separated salt solutions on paper
1868 Goppelsroeder,F.
Introduced  paper  strip  (capillary  analysis)
analysis of dyes, hydrocarbons, milk, beer,
colloids, drinking and mineral water, plant
and animal pigments
1906-1907 Twsett,M.
Separated  chloroplast  pigment  on  CaCO3
solid  phase  and  petroleum  ether  liquid
phase
1931 Kuhn,R.et.al Introduced liquid-solid chromatography for
separating egg yolk xanthophylls
1940 Wilson,J.N
Wrote  first  theoretical  paper  on
chromatography:  assumed  complete
equilibration and linear sorption isotherms,
qualitatively  defined  diffusion,  rate  of
adsorption and isotherm non linearity
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1941 Tiselius,A.
Developed  liquid  chromatography  and
pointed out frontal analysis, elution analysis
and displacement development
1944
Consden, R.,Gordon,A.H.,
& Martin, A.J.P
Developed paper chromatography
1946 Claesson,S.
Developed  liquid-solid  chromatography
with frontal and displacement development
analysis
1951 Cremer,E. Introduced gas-solid  chromatography
1952
James,A.T.,andMartin,A.J.P
.
Introduced gas-liquid  chromatography
1957 Golay,M
Reported the development of open tubular
columns
High Performance Liquid Chromatography
High performance liquid chromatography is the fastest growing analytical technique
for the analysis of the drugs. Its simplicity, high specificity and wide range of sensitivity make
it ideal for an analysis of many drugs in both dosage forms and biological fluids. HPLC was
developed in the late 1960s and 1970s. Today it is widely accepted separation technique for
both  sample  analysis  and  purification  in  variety  of  areas.  The  successful  use  of  liquid
chromatography requires the right combination of a variety of operating conditions such as
the type of,
• Column packing.
• Mobile phase and its flow rate.
• Column length and diameter.
• Column temperature and sample size.
General uses of HPLC
1. Separation of wide variety of compounds, organic, inorganic and biological
compounds,  polymers,  chiral  compounds,  thermally liable  compounds  and
small ions to macro molecules.
2. Analysis of impurities.
3. Analysis of both volatile and nonvolatile compounds.
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4. Determination of neutral ionic or zwitter ionic molecules.
5. Isolation and purification of compounds.
6. Ultra trace to preparative and process scale separations.
7. Qualitative and quantitative method.[6]
Guide to Liquid Chromatography Mode Selection
Selection of chromatography mode is based upon the analyte polarity, solubility and
ionic nature. [7] A guide to liquid chromatography mode selection is represented in fig no: 1
Fig. No: 1 Guide to Liquid Chromatography Mode Selection Reverse Phase
HPLC
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phase
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MW<2000
MW>2000
Fig.No: 2 Block diagram showing the components of an HPLC instrument
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Liquid, solid or bonded phase
Anion exchange/ion pair
Cation exchange/ion pair
Size exclusion, aqueous mobile
phase
Size exclusion, non-aqeous mobile
phase.
Sample
Non-ionic
Ionic
Water soluble
Water insoluble
High polarity
Acidic
Basic
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F
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Reverse phase column packing
The  liquid-liquid  partition  chromatography  uses  a  stationary  phase  consisting  of
liquid layer adsorbed to a surface of silica or alumina. In case of bonded phase or reverse
phase HPLC uses a stationary phase consisting of an organic moiety chemically bonded to the
surface of silica through the surface silanol groups. Since the organic moieties are generally
long-chain hydrocarbons, the mobile phases are generally polar. In this mode, the more polar
solutes are eluted first while the non-polar compounds are eluted later. The silanol group can
react with a chlorosilane group to form the popular (ODS & C18) octaydecylisilane packing.
E.g. Octaydecylisilane (ODS or C18).
  CH3                               CH3
  Si      OH  +   Cl  –   Si  – (CH2)17 – CH3                 Si – O – Si – (CH2)17 – CH3 +HCl
  CH3                                CH3
For silica based bonded materials, the suitable working pH range is 2 - 8. At pH
values of less than 2, the Si-C bond is attached and at the higher pH values, hydrolysis of the
siloxane takes place which leads to degradation or destruction of the packing. In most of the
applications of RP-HPLC, elution is carried out with highly polar solvents such as methanol,
Acetonitrile or tetrahydrofuran in various concentrations. [9a]
Reverse phase mobile phase
The primary constituent of RP-HPLC mobile phase is water. Water miscible solvents
such as methanol, ethanol, Acetonitrile, dioxane, tetrahydrofuran and dimethyl formamide are
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added to adjust the polarity of the mobile phase. Additionally acids, bases,  buffers and/or
ionic  surfactants  are  added.  The  water  should  be  of  high  quality,  either  distilled  or
demineralised water.
The  most  widely  used  organic  modifiers  are  methanol,  Acetonitrile  and
tetrahydrofuran. Methanol and Acetonitrile have comparable polarities but Acetonitrile is an
aprotic  solvent.  Ethanol,  1-propanol  and  2-propanol  are  also  useful  but  less  polar  than
methanol. Dioxane, tetrahydrofuran are aprotic solvents that are less polar than Acetonitrile.
Reverse  phase  mobile  phases  are  generally  non-flammable  due  to  high  water  content.
Degassing is quite important with reverse phase mobile phases. [9b]
6. DETECTORS10
The function of the detector in HPLC is to monitor the mobile phase emerging
from the column. The output of the detector is an electrical signal that is proportional
to some property of the mobile phase and/or the solutes.
LC detectors are basically of two types.
Bulk  property  detectors  respond  to  mobile  phase  bulk  property  such  as
refractive index, dielectric constant or density. Solute property detectors respond to
some property  of  solutes,  such  as  UV absorbing,  fluorescence,  diffusion  current,
which are not possessed by the mobile phase
Most common HPLC detectors
• UV-Visible absorbance detector (UV-VIS)
• Photo-diode array detector (PDA)
• Fluorescence detector
• Electrochemical (ECD)
• Refractive Index (RI)
• Mass detectors (MS)
• Conductometric detector
• Chiral detector (Polarimetric & circular dichrosim)
• Evaporative Light scattering detector (ELSD)
• Radiochemical detector
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Characteristics of ideal detectors
1. Adequate sensitivity.
2. Good stability and reproducibility.
3. A linear response to analyte.
4. A short response time that is independent of flow rate.
5. High reliability.
6. Minimal internal volume in order to zone broadening. [9c]
 Liquid chromatographic detectors are of two basic types,
1. Differential or bulk property detector
2. Selective or solute property detector
Differential or bulk property detector
Differential or bulk property detector provides a differential measurement of a
bulk property that is possessed by both the analyte and the mobile phase.
e.g., Refractive index, dielectric constant.
Selective or solute property detector
Measure the  property of  an analyte  which  is  not  possessed  by the  mobile
phase.
e.g., UV absorbance, fluorescence.
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1.5 ICH GUIDELINES FOR ANALYTICALMETHOD 
VALIDATION (11)
Method  validation  is  the  process  to  confirm  that  the  analytical  procedure
employed for a  specific test  is  suitable for  its  intended use.   Methods need to  be
validated or revalidated,
 Before their introduction into routine use
 Whenever the conditions change for which the method has been validated,
e.g., instruments with different characteristics.
 Whenever the method is changed and the change is outside the original scope
of  the  method.  The  International  Conference  on  Harmonization  (ICH)  of
Technical Requirements for the Registration of Pharmaceutical for human use
has developed a consensus text on the validation of analytical procedures. 
REASONS FOR VALIDATION
1. Enables scientists to communicate scientifically and effectively on technical
matters.
2. Setting  standards  of  evaluation  procedures  for  checking  complaints  and
taking remedial measures 
3. Retrospective validation is useful for trend comparison of results compliance
to cGMP/GLP.
4. Closer interaction with pharmacopoeia harmonization particularly in respect
of impurities determination and their limits. 
5. For taking appropriate action in case of non – compliance.
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6. To  provide  high  degree  of  confidence  that  the  same  level  of  quality  is
consistently built into each unit of finished product from batch to batch. 
As quality control process is  not static,  some form of validation /  Verification should
continue till the validated process is in use.
The parameters as defined by the ICH and by other organizations
 Specificity
 Selectivity
 Precision 
o Repeatability
o Intermediate precision
o reproducibility
 Accuracy
 Linearity
 Range
 Limit of detection
 Limit of quantification
 Robustness
 Ruggedness 
A) Specificity and selectivity
i. Selectivityistheabilitytomeasureaccuratelyandspecificallytheanalyteinthep
resence of components that may be expected to be present in the sample
matrix.
ii. Specificity for an assay ensures that the signal measured comes from the
substance  of  interest  and that  there  is no interference  from  excipients
and/or degradation products and/or impurities.
iii. Determination of this can be carried out by assessing the peak identity and
purity.
iv. Diodearray  detectors  can  facilitate  the development and  validation of
HPLC  assays.  Spectra] data  obtained  from  diode  array  detectors,
effectively  supplement  the retention  time  data  for  peak  identification,
also  spectral  manipulation often provides  information  about  the  peak
purity.  The  table  below  lists  several  of  the  techniques  available  for
assessing peak identity and purity.
v. The  purity index is  a  measure  of  the  peak's  relative  purity, measured
using a  full comparis on of spectral data for the leading and training edge
of the peak. A value of 1.5 is commonly accepted to indicate a pure peak.
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But>1.5wouldindicatethepresence of an impurity.
B) Precision
The precision of  an analytical  procedure expresses  the closeness of  agreement
between  a  series  of  measurement  obtained  from  multiple  sampling  of  the  same
homogenous  sample  under  the  prescribed  conditions.  Precision  of  an  analytical
procedure is usually expressed at the variance, standard deviation or coefficient  of
variation of a series of measurements.  
 Validation of tests for assay and for quantitative determination of impurities
includes an investigation of precision.
Precision is a measure of the reproducibility of the whole analytical method
(including  sampling,  sample  preparation  and  analysis) under normal operating
circumstances. Precision is determined by using the method to assay a sample for a
sufficient number of times to
Obtain statistically valid results (i.e.between6-10). The  precision is then  expressed
as the relative standard deviation
                          STDdevx100%
%RSD =
 Mean
Repeatability
Express the precision under the same operating conditions over a short interval
of time.  Repeatability is also termed as intra - assay precision. It should be assessed
using  a  minimum  of  nine  determinations  covering  the  specified  range  for  the
procedure  (e.g.  three  concentration/three  replicates  each)  or  a  minimum  of
determinations at 100% of the test concentration.
Intermediate precision
          The extent to which intermediate precision should be established depends on
the circumstances under which the procedure is intended to be used.  The applicant
should  establish  the  effects  of  random  events  on  the  precision  of  the  analytical
procedure. Typical variations to be studied include days, analysts, equipment, etc.
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Reproducibility
          Reproducibility  is  assessed  by  means  of  an  inter-laboratory  trial.
Reproducibility should be considered in case of the standardization of an analytical
procedure, for instance inclusion of procedures in Pharmacopoeias.  
C) Accuracy
The accuracy of  an analytical  procedure expresses  the closeness  of  agreement
between the value which is  accepted either  as  a  conventional  true value or  on an
accepted reference value and the value found.
Assay 
- Assay of Active Substance
- Assay of Medicinal products
Several methods are available to determine the accuracy.
a) Application of an analytical procedure to an analyte of known purity   (e.g.
reference material).
b) Comparison of the results of the proposed analytical procedure with those of a
second well-characterized procedure, the accuracy of which is stated and/or
defined (independent procedure)
c) Application of the analytical procedure to synthetic mixtures of the product
components to which known quantities of the substance to be analyzed have
been added.
Impurity (Quantification)
          Accuracy should be assessed on sample (substance /products) spiked with
known amounts of impurities.  It should be clear how the individual or total impurities
are to be determined.
E.g.  Weight / Weight or area percent.
D) Linearity and range 
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Linearity of an analytical procedure is its ability (with in a given range) to
obtain test results which are directly proportional to the concentration (amount) of
analyte in the sample.
 Linearity should be evaluated by visual inspection of a plot of signals as a
function of  analyte concentration or content.   If  there is  a linear relationship,  test
results  should  be  evaluated  by  appropriate  statistical  methods.   For  example,
calculation of a regression line by the method of least square.  Therefore data from
regression line itself may be helpful to provide mathematical estimates of the degree
of linearity.
o Range of an analytical procedure is the interval between the upper and
lower concentration (amounts) of analyte in the sample including these
concentrations for which it has been demonstrated that the analytical
procedure has a suitable level of precision, accuracy and linearity.
The following minimum specified ranges should be considered
• For the assay of an active substance or a finished product normally from 80-
120 percent of the test concentration.
• For the content uniformity, covering a minimum of 70-130 percent of the test
concentration.
• For  dissolution  testing,  20%  over  the  specified  range  (e.g.),  If  the
specifications for a controlled release product cover a region from 20% after 1
hour, upto 90% after 24 hours, the validated range would be 0-110% of label
claim.
• For the determination of  an impurity,  the reporting level  of an impurity to
120% of the specifications.
E) Limit of Detection 
The  detection  limit  is  determined  by  the  analysis  of  samples  with  known
concentration of analyte and by establishing that minimum level at which the analyte
can reliably detected.
i. Based on visual evaluation
          Visual evaluation may be used for non-instrumental methods but may be used
with instrumental methods.   
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ii. Based on signal to noise ratio
Determination  of  the  signal-to-noise  ratio  is  performed  by  comparing
measured signals from samples with known low concentrations of analyte with those
of blank samples and establishing the minimum concentration at which the analyte
can  be  reliably  detected.  A signal-to-noise  ratio  3  or  2:1is  generally  considered
acceptable for estimating the detection limit.
iii. Based on the standard deviation of the response and the slope
The detection limit (DL) may be expressed as
D L = 3.3/S
Where,     
σ = the standard deviation of the response
S = the slope of the calibration curve
The slope, S may be estimated from the calibration curve of the analyte. The
estimate of σ may be carried out in a variety of ways.
a. Based on the Standard Deviation of the Blank
Measurement  of  the  magnitude  of  analytical  background  response  is
performed by analyzing an appropriate number of blank samples and calculating the
standard deviation of these responses.
b. Based on the calibration curve
          A specific calibration curve should be studied using samples containing an
analyte in the range of DL. The residual standard deviation of a regression line or the
standard  deviation of  y-intercept  of  regression lines  may be used  as  the  standard
deviation 
F) Limit of Quantification
The quantification limit is generally determined by the analysis of samples 
with known concentrations of analyte and by establishing the minimum level at which
the analyte can be quantified with acceptable accuracy and precision
i. Based on visual evaluation
            Visual evaluation may be used for non-instrumental methods but may also be
used with instrumental methods.
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ii. Based on Signal- to-Noise ratio
Determination  of  the  Signal-to-Noise  ratio  is  performed  by  comparing
measured signals from samples with known low concentrations of analyte with those
of blank samples and by establishing the minimum concentration at which the analyte
can be reliably quantified. A typical Signal- to-Noise ratio is 10:1.
iii. Based on the Standard Deviation of the Response and the slope 
The quantification limit (Q L) may be expressed as
QL=
10σ
S
Where,
σ = the standard deviation of the response
S = the slope of the calibration curve
The slope S may be estimated from the calibration curve of the analyte. The
estimation may be carried out in a variety of ways including,
a. Based on standard deviation of the blank
          Measurement of the magnitude of analytical background response is performed
by an appropriate number of blank samples and calculating the standard deviation of
these responses.
b. Based on the Calibration Curve
          A specific calibration curve should be studied using samples containing an
analyte in the range of QL. The residual standard deviation of a regression line or the
standard deviation of  y-intercepts of regression lines may be used as the standard
deviation
G)  Robustness
          The evaluation of robustness should be considered during the development
phase  and  depends  on  the  type  of  procedure  under  study.   It  should  show  the
reliability of an analysis with respect to deliberate variations in method parameters.
Examples of typical variations are
 Stability of analytical solutions.
 Extraction time.
In case of liquid chromatography, examples of typical are
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• Influence of variation of pH in a mobile phase,
• Influence of variations in mobile phase composition,
• Different columns (different lots and / or suppliers),
• Temperature,
• Flow rate.
In the case of gas-chromatography, examples of typical variations are
• Different columns (different lots and/or suppliers),
• Temperature,
• Flow rate.
F)  Ruggedness
          The United States pharmacopoeia (USP) define ruggedness as the degree of
reproducibility of test results obtained by the analysis of the same samples under a
variety of normal test conditions such as different labs, different analysis, different
lots of reagents etc.  Ruggedness is a measure of reproducibility of test results under
normal  expected  operational  conditions  from  laboratory  to  laboratory  and  from
analyst to analyst. 
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2. DRUG PROFILE
2.1 Isoniazid12
Structure
Nomenclature             :  Isonicotinohydrazide
Molecular Formula    :  C6H7N3O 
Molecular Weight     :  137.1 g/mol
Appearance : A white or almost white, crystalline powder or 
                                                                            Colourless crystals 
Solubility :  freely soluble in water, sparingly soluble in 
                                                                          Alcohol
Category                            :  Anti–Tuberculosis
2.2 Rifampicin13
Structure
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Nomenclature      :  (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-
pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-
yl)imino]methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-
1(28),2,4,9,19,21,25(29),26-octaen-13-yl acetate
Molecular Formula : C43H58N4O12 
Molecular Weight        : 823 g/mol
Appearance :  Reddish brown colour, brownish red crystalline 
                                                  Powder
Solubility :  Sparingly soluble in water, freely soluble in 
                                                   Methanol, sparingly soluble in acetone, ethanol(96%).
Category                             :  Anti–Tuberculosis
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3. REVIEW OF LITERATURE
Shah Y,  et al.,14 developed a liquid chromatographic procedure for the analysis of Rifampicin
(RIF)  and  Isoniazid  (ISN)  in  pharmaceutical  dosage  forms  utilizing  reverse  phase
chromatography.  Isolation  of  analytes  was  carried  out  under  isocratic  condition  with  an
octaydecylisilane column and an aqueous mobile phase containing methanol (75%) and 0.02M
disodium hydrogen orthophosphate (25%) with pH 4.5 was adjusted with orthophosphoric acid.
The detection was done at 254mm. The method was unique in analysing Rifampicin precisely in
liquid combination with Isoniazid particularly in liquid formulation. The method was specific
and could distinctly isolate the degradation product in suspension.
Glass  BD, et  al.,15developed  a  stability  –  indicating  HPLC  method  for  the  simultaneously
determination of Rifampicin, Isoniazid and pyrazinamide in a fixed dose combination. The best
separation  and  reasonable  short  retention  times  were  produced  on  the  micro  bondapak  C18,
4.6x250  mm column,  10  microns/125  using  ACN:tBAH  (42.5:57.5,  v/v)  (0.0002M)  as  the
mobile phase with  optimized rate at final pH.
Caller E, et al.,16 developed and validated simple and accurate liquid chromatographic method
for  estimation  of  Isoniazid  (ISN),  pyrazinamide  (PZA)  and  Rifampicin  (RIF)  in  combined
dosage forms. Drugs were chromatographed on a reverse phase C18 column using a mobile phase
gradient and monitored at the corresponding maximum of each compounds. The method was
linear (r2>0.999), précised (RSD%:0.50 % for ISN, 0.12% for PYR and 0.98% for RIF), accurate
(overall  average  recovery  yields  98.55%  for  ISN,  98.51  for  PYR  and  98.56  for  RIF)  and
selective.
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Mohan  B,  et  al.,17  reported  USP gradient  HPLC  method  for  quantitative  determination  of
Rifampicin,  Isoniazid  and  pyrazinamide  in  fixed  dose  combination  (FDC)  formulations   to
determine its ability to resolve major degradation products of Rifampicin, viz  3-formylrifamycin
SV, Rifampicin N-oxide, 25-desacetyl Rifampicin, Rifampicin quinine andisonicotinylhydrazone
an interaction product of 3-formylrifamycin and Isoniazid.  The first  observation was that  the
requirements of theoretical plates listed in the given method were met for Rifampicin, but not for
Isoniazid and pyrazinamide even on columns of different makes. The resolving power of the
method was also dependent upon make of the column. On two of the three columns of the three
tested, it was able to resolve most degradation products, except Rifampicin N-oxide and 25 –
desacetylRifampicin,  which  were  overlapping.  The  method  was  modified  and  an  overall
satisfactory resolution for all components was obtained by changing the buffer organic modifier
ratio of solution B in the gradient from 45:55 to 55:45 and decreasing the flow rate from 1.5 to
1.0 ml/min, keeping all other conditions constant.
Panchangul  R,  et  al., 18  developed  a  reversed  phase  HPLC  method  for  the  simultaneous
estimation  of  Rifampicin  and  its  main  metabolite  in  plasma  and  urine  in  presence  of
pyrazinamide and Isoniazid. The assay involved simple liquid extraction of drug, metabolite and
internal standard (rifapentine) from biological specimens and their subsequent separation on aC18
reversed phase  column and single wave length UV detection.  In  plasma as  well  as  in  urine
samples,  all  the  three  compounds  of  interest  eluted  within 17  min,  using methanol:  sodium
phosphate buffer (pH 5.2:0.01mm) (65.35, v/v) as mobile phase under isocratic conditions. It
was  established  that  Isoniazid,  pyrazinamide  and  ascorbic  acid  (added  to  prevent  oxidative
degradation  of  analytes)  did  not  interfere  with  the  analyte  peaks.  Recoveries  (extraction
efficiency) for drug were greater than 90 % in both plasma and urine, whereas for metabolite the
values were found to be 79 and 86 % in plasma and urine respectively. The plasma and urine
methods were précised and accurate for both the analytes. The method developed was proved to
be suitable for simultaneous estimation of Rifampicin and desacetylRifampicin in plasma and
urine samples.
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Smith  PJ, et  al.,19developed  simple  and  sensitive  high  performance  liquid  chromatographic
(HPLC)  method  suitable  for  assaying  RIF,  INH  and  PZA in  bio  availability  studies.  RIF,
desacetylRifampicin (DRIF), INH and PZA were extracted simultaneously from plasma using a
solid phase extraction column. RIF and DRIF were quantitated by  using an 80% Acetonitrile
10.1% trifluoroacetic acid (TFA)  as mobile phase and  C8 reversed phase column .INH and PZA
were also quantitated by using  C8 reversed phase column, but mobile phase was  3% Acetonitrile
10.6% TFA. Mean recovery of RIF, DRIF and PZA from plasma was well over90% and over
70%  for  INH.  Calibration  graphs  were  linear  for  all  the  drugs  in  their  therapeutic  range.
Correlation coefficients were all above 0.9995.
Khuhawar  MY,  et al., 20  developed  liquid  chromatographic  method  for  determination  of
Isoniazid, Pyrazinamide andRifampicin from pharmaceutical preparations and blood. Isoniazid
(ISN), pyrazinamide (PZA) and Rifampicin (RIF) were separated on YMC ODS column. ISN
was derivated with 2 – fluorence – carboxaldehyde (FCA). The separation was achieved using
ethanol  –  chloroform –  Acetonitrile  water  by isocratic  elution  and  detected  at  337mm. The
detection limits were 0.11 ng, 0.2 ng and 113 ng/ injection (5 µ l)  for ISN, PZA and RIF,
respectively. The method of analysis was applied to the pharmaceutical preparations and in the
blood samples of the patients suffering from tuberculosis after undergoing chemotherapy with
ISN, PZA and RIF. The amounts quantitated in blood showed 0/97 to 1.58 µg/ml ISN, 3.44 to
409 µg/ml Pz and 1.98 to 3.5 µg/ml RIF with coefficient of variations 0.8 – 1.8%, 0.9 – 1.3%
and 0.8 – 2% respectively.
Ali.  J,  et  al., 21  developed  simple,  selective,  and  précised  and  stability  indicating  high
performance thin layer chromatographic (HPILC) method. The compounds were separated an
aluminium  backed  silica  gel  60  F254  plates  with  r-hexane:  2-propanal:  acetone:  ammonia:
formic acid, 3:3.8:2.8:0.3:0.1 (v/v) as mobile phase. The correlation coefficients were 0.994 and
0.997  for  Isoniazid  and  Rifampicin  respectively.  The  values  of  slope  and  intercept  of  the
calibration plots were 3.755 +/_ 0.22 and 3099.1+/_ 51.21 respectively, for Isoniazid and 4.0957
Department of Pharmaceutical analysis, K.M college of pharmacy, Madurai. Page 28
                                                                                                                                                    Literature Review
+/_   0.25and 3567.6 +/-  61.11 respectively.  For  Rifampicin.  The method was validated for
precision, recovery and robustness. The limits of detection and quantification were 2010.51 and
60+/- 1.05 ng respectively, for Isoniazid and 2510.63 and 75+/- 1.12ng respectively. In stability
tests the drugs were susceptible to acid and basic hydrolysis, oxidation and photo degradation.
Kakde  R, et  al., 22 developed  three  spectrophotometric  methods  for  the  determination  of
Rifampicin  and  Isoniazid  in  pharmaceutical  preparations.  First  method  was  based  on  the
determination of graphical absorbance ratio at two selected wavelengths. In the second method
derivative spectroscope was used to eliminate spectral interference and the third method was
based on the additivity of absorbance. All the three methods were found to be simple, rapid, and
accurate and could be adopted in routine analysis of drug in formulations.       
Balbo MS,et al.,23 developed sensitive and reproducible stir bar sorptive extraction and HPLC –
UV detection  (SBSE/HPL -  UV)  method  for  therapeutic  drug  monitoring  of  Rifampicin  in
plasma samples.  Separation was obtained using reverse phase C8 column with UV detection
(254mm). The mobile phase consisted of methanol: 0.25N sodium acetate buffer, pH 5.0 (58:42,
v/v). The SBSE/HPLC - UV method was linear over a working range of 0.125 – 50.0 µg ml-1.
The intra assay and inter assay precision and accuracy was studied at three concentrations (1.25,
6.25 and 25.0 µg ml-1). The intra assay coefficients of variation (CVS) for all compounds were
less  than  10%.  Limit  of  quantification  was  0.125  µg  ml-1.  Stability  studies  showed  that
Rifampicin was stable in plasma for 12 hour after thawing and the samples were also stable for
24 hour after preparation.
Satavi A, et al., 24 developed a simple, rapid, sensitive and accurate indirect spectrophotometric
method  for  the  micro  determination  of  Isoniazid  (INH)  in  pure  form  and  pharmaceutical
formulations.  The  procedure  was  based on  the reaction of  copper  (II)  with  Isoniazid in  the
presence of neocuproine (NC). In the presence of neocuproine, copper (II) was reduced easily by
Isoniazid to a cu (I) neocuproine complex, which showed an absorption Maximum at 454nm. By
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measuring the absorbance of the complex at this wavelength, Isoniazid could be determined. This
method was applied to the determination of Isoniazid in pharmaceutical formulation and enabled
the determination of the Isoniazid in microgram quantities. The results obtained for the assay of
pharmaceutical  preparative  compared  well  with  those  obtained  by  the  official  method  and
demonstrated good accuracy and precision.
Rui L, et al., 25 developed fluorimetric method for the determination of Isoniazid by oxidation
with cerium (IV) in a multicommutated flow system. A multicommutated flow system for the
indirect  fluorimetric  determination  of  Isoniazid  procedure  was  based  on  the  oxidation  of
Isoniazid by cerium (IV) and monitoring of the fluorescence intensity of the formed cerium (III).
Linear calibration plots up to 1.37 Mg Ml-1, with a relative standard deviation of less than 1.6%
(n=12)  and  a  sample  through put  of  about  50  samples  per  hour,  were  obtained.  The  lower
detection  limit  was  34.3ng  Ml-1.  The  methodology  was  evaluated  in  the  determination  of
Isoniazid  in  pharmaceutical  preparations  and  the  effect  of  potential  interferences  was
investigated.
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4. AIM AND PLAN OF WORK
Aim and scope  
                    Isoniazid and Rifampicin is official in I.P, B.P, and U.S.P.  From the literature survey,
it was found that there were only few RP-HPLC methods reported for the estimation of Isoniazid and
Rifampicin in pharmaceutical dosage forms.
                    Hence, the aim of present work is to develop RP-HPLC method for estimation of
Isoniazid and Rifampicin from the tablet  dosage form and to validate the developed RP-
HPLC method by validation parameters as per ICH guidelines.
Plan of present work 
 Method development (By reverse phase HPLC).
 Validation of the developed method (By using following parameters).
      a. System suitability studies
b. Accuracy
c. Precision
d. Linearity
                              e. Specificity
                              f. Robustness
                              g. Limit of detection
h. Limit of quantification
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 5. MATERIALS AND INSTRUMENTS USED 
S.No. NAME MODEL MANFACTURER/SUPPLIER
      1.
Weighing balance AUM220D        Shimadzu
       2.
Sonicator Sonorex Sonorex dg 10p
       3.
pH Meter 9087         ELICO pH METER
       4. 
HPLC-UV,PDA Waters e 2116          Waters
       5.
Colum Zodiac C18          Zodiac
a) Apparatus / Instruments used:
b)  Active Ingredients used:
S.No. NAME SPECIFICATION 
1. Isoniazid As Reference standard
2. Rifampicin As Reference standard
c) Chemicals used:
S.NO NAME MODEL MANFACTURER/SUPPLIER
Pottasiumdihydrogen
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1. orthophosphate HPLC Rankem Chemicals
2. Methanol HPLC Rankem Chemicals
3. Phosphoric acid HPLC         Merck Chemicals
4. Milli-Q Water HPLC         In House production
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6. RP-HPLC METHOD DEVELOPMENT
            In case of analytical method development and for drugs analysts should decide whether 
the given analytical method is suitable for the assay of the drug. The method development of new
improved method usually trailers existing approaches and instrumentation to the current analyte, 
as well as to the final needs or requirements of the method.
            In the development stage, decision regarding choice of column, mobile phase, detectors 
and method of quantitation must be addressed. In this way, development considers all the 
parameters pertaining to any methods.
.
(1) Selection of stationary phase
Proper  selection  of  the  stationary  phase  depends  up  on  the  nature  of  the  sample
andchemical profile.  The drug selected for the present study was polar compound and could be
separated either by normal phase chromatography or reverse phase chromatography.
From literature survey, it was found that different C18columns could be appropriately used
for the separation ofIsoniazid and Rifampicin.
(2) Selection of wavelength 
The sensitivity of the HPLC depends upon the selection of detection wavelength.  An
ideal wavelength is one that gives good response for both drugs to be detected.  The wavelength
for measurement was selected as 263 nm from the absorption spectrum.
(3) Selection of mobile phase 
            The mobile phase was selected andchromatograms were recorded, trails were done on
Isoniazid and Rifampicin. 
ASSAY METHOD DEVELOPMENT
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The objective of  this  experiment  was to  optimize the assay method for  simultaneous
estimation of  Isoniazid and  Rifampicinbased on the literature survey made and  the methods
given in pharmacopoeia. Trials done for optimization were as follows: 
Trials
Buffer preparation:  17.418 gm of Potassium Hydrogen Orthophosphate was mixed with
1000 ml of Mille-Q water and shaked for 15min and degassed. 
Trial 1: 
 Mobile phase A                            : Potassium Hydrogen Orthophosphate
 Mobile phase B                            : Methanol
Chromatographic conditions 
Column  : Agilent Zorbax Sb-C18, (4.6 × 250 mm, 5 µ)
Detector wavelength                     : 263 and 274 nm
Column temperature                : 30 0C 
Injection Volume                    : 10 µl
Flow rate                                       : 1.0 ml/min
Runtime                                        : 15 min
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Observation: Tailing was not satisfactory for both Rifampcin and Isoniazidand the retention
time of Rifampicin and Isoniazid were found to be 3.17 and 2.6 minutes respectively.
Trial 2: (OPTIMIZED METHOD)
Buffer Preparation:  17.418 gm of Potassium Hydrogen Orthophosphate was mixed with
1000 ml of Mille-Q water and shaked for 15min and degassed. 
Mobile phase A                         : Potassium Hydrogen Orthophosphate
Mobile phase B                         : Methanol
Chromatographic Condition:
Column   : AgilentZorbax Sb-C18, (4.6 × 250 mm, 5 µ) 
Column temperature  : 300C
Inj. Volume : 10 µl
Flow rate                                 : 1.0 ml/min
λmax : 263 nm  
Run time                                 : 15 min
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Observation: Tailing was satisfactory for both Rifampcin and Isoniazid and the retention time
of  Rifampicin and Isoniazid were found to be 3.17 and 2.6 minutes respectively.
Sample preparation
Preparation of sample solution of Isoniazid and Rifampicin for trials:    
10  tablets  were  weighed  accurately  and  finely  powdered.  Tablet  powder  of902.55  mg
equivalent to 450 mg of Rifampicin and 300 mg of Isoniazid was weighed and transferred into a
50 ml  standard  volumetric  flask.  After  this  25 ml  of  HPLC Water  (diluent)  was  added  and
sonicated for 30 minutes with intermittent shaking and cooled to room temperature. Volume was
made with HPLC Water (diluent) and mixed well.
            5ml of stock was pipetted out in to a 25ml standard volumetric flask and finally volume
was made up with 25ml HPLC water (diluents). This solution was referred as Rifampicin and
Isoniazid sample solution that contained 1800 µg of Rifampicin and 1200 µg of Isoniazid per ml
respectively.
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The scheme of dilution was presented as follows
Dilution chart:
902.55 mg        50 ml (9000µg/ml) [Rifampicin ]
                                            (6000µg/ml) [Isoniazid]
5ml 25ml (1800µg/ml) [Rifampicin ]
                                                                   (1200µg/ml)  [Isoniazid]
Standard solution preparation:
450 mg of Rifampicin (RIF) and 300 mg of Isoniazid (ISN) was accurately weighed and
transferred into a 50 ml standard volumetric flask. After this 5 ml of HPLC water was added and
sonicated for 30 minutes with intermittent shaking and cooled to room temperature. Volume was
made with diluent and mixed well.
 5ml of stock was pipetted out in to a 25ml standard volumetric flask and finally volume was
made  up  with  25ml  HPLC  water  (diluents).  This  solution  was  referred  as  Rifampicin and
Isoniazid sample solution that contained 1800 µg of Rifampicin and 1200 µg of Isoniazid per ml
respectively.
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The scheme of standard dilution was presented as follows
Dilution chart:
Standard preparation 
450 mg of RIF                                    50ml  (9000µg/ml) [Rifampicin ]
           Or                                                        (6000µg/ml) [Isoniazid]   
300 mg of INH
                                                                                                      (1800µg/ml) [RIF ]
                                                5ml                          25ml  (1200µg/ml) [ISN]
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7. METHOD VALIDATION 
VALIDATION
According to ICH guidelines method validation can be defined as “Establishing documented
evidence,  which  provides  a  high  degree  of  assurance  that  a  specific  activity  will  consistently
produce  a  desired  result  or  product  meeting  its  predetermined  specifications  and  quality
characteristics”.Such validated analytical method for qualitative and quantitative testing of the drug
molecule  assume  greater  importance  when  they  are  employed  to  generate  quality  and  safety
compliance data during development, pre-formulation studies and post approval of drug products. 
The ICH of Technical Requirements for the Registration of Pharmaceutical for human use
has developed a consensus text on the validation of analytical procedures. The document includes
definitions for eight validation characteristics
Parameters Used for Assay Validation
The validation of the assay procedure was carried out using the following parameters.
1) Parameters:
1.1 System suitability 
1.2 Specificity
1.3 Method Precision 
1.4 Linearity & range 
1.5 Accuracy / Recovery studies 
1.6 Robustness 
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PREPARATION OF STANDARD AND SAMPLE SOLUTION:
STANDARD PREPARATION:
Buffer Preparation:  17.418 gm of Potassium Hydrogen Orthophosphate was mixed
with 1000 ml of Mille-Q water and shaked for 15min and degassed. 
Mobile phase A                         : Potassium Hydrogen Orthophosphate
Mobile phase B                         : Methanol
Chromatographic Condition:
Column  : Agilent Zorbax Sb-C18, (4.6 × 250 mm, 5 µ) 
Column temperature  : 300C
Inj. Volume       : 10 µl
Flow rate         : 1.0 ml/min
λmax                 : 263 nm  
Runtime : 15 
Sample preparation
Preparation of sample solution of Isoniazid and Rifampicin for trials:    
10  tablets  were  weighed  accurately  and  finely  powdered.  Tablet  powder  of  902.55  mg
equivalent to 450 mg of Rifampicin and 300 mg of Isoniazid was weighed and transferred into a 50
ml standard volumetric flask. After this 25 ml of HPLC Water (diluent) was added and sonicated
for 30 minutes with intermittent shaking and cooled to room temperature. Volume was made with
HPLC Water (diluent) and mixed well.
5ml of stock waspipetted out in to a 25ml standard volumetric flask and finally volume was
made up with 25ml HPLC water (diluents). This solution was referred as Rifampicin and Isoniazid
sample  solution  that  contained  1800  µg  of  Rifampicin  and  1200  µg of  Isoniazid  per  ml
respectively.
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The scheme of dilution was presented as follows
Dilution chart:
902.55 mg       50 ml  (9000µg/ml) [Rifampicin ]
                                            (6000µg/ml) [Isoniazid]
  5ml                25ml   (1800µg/ml) [Rifampicin ]
                                                                  (1200µg/ml)  [Isoniazid]
Standard preparation 
Standard solution preparation:
450 mg of  Rifampicin (RIF) and 300 mg of  Isoniazid (ISN) was accurately weighed and
transferred into a 50 ml standard volumetric flask. After this 5 ml of HPLC water was added and
sonicated for 30 minutes with intermittent shaking and cooled to room temperature. Volume was
made with diluent and mixed well.
 5ml of stock waspipetted out in to a 25ml standard volumetric flask and finally volume was
made up with 25ml HPLC water (diluents). This solution was referred as Rifampicin and Isoniazid
sample  solution  that  contained  1800  µg  of  Rifampicin  and  1200  µg of  Isoniazid  per  ml
respectively.
The scheme of standard dilution was presented as follows
Dilution chart:
 450 mg of RIF                                                    50ml  (9000µg/ml) [Rifampicin ]
              Or                                                               (6000µg/ml) [Isoniazid]   
300 mg of INH
                                                                                                                           (1800µg/ml) [RIF ]
                                                                         5                         25ml     (1200µg/ml) [ISN]
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 SYSTEM SUITABILITY
 System suitability is the checking of a system to ensure system performance before or during
the analysis of unknowns. Before performing any validation experiment, HPLC method and the
procedure should be capable of providing data of acceptable quality. These tests are to verify that
the resolution and repeatability of the system are adequate for the analysis to be performed. It is
based on the concept that equipment, electronics, analytical operations and sample constitute an
integral  system  that  can  be  evaluated  as  a  whole.  System  suitability  parameters  and
recommendations were shown in the table no.3
 Table no. 3 System suitability parameters and recommendations
S.N
o
Parameters Recommendations
1 Theoretical plates (N) >2000
2 Tailing factor (T) ≤ 2
3 Resolution (Rs)
> 2 between peak of interest and the closest eluting potential
interference
4 Repeatability RSD ≤ 1% for N ≥5 is desirable
5 Capacity factor (k1) > 2.0
6 Relative retention Not essential as long as the resolution is stated
Procedure:
 A standard solution was prepared by using Isoniazid and Rifampicin working standards as
per test method and was injected six times into the HPLC system.
 The  system  suitability  parameters  were  evaluated  from  standard  chromatograms  by
calculating the % RSD from ten replicate injections for Isoniazid and Rifampicin retention
times and peak areas. Resulted chromatogram was shown in the chromatogram fig. no.3. 
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Fig no.3Chromatogram of standard 1
Table no.4                               Data for system suitability of ISONIAZID
Name: ISONIAZID 
SampleNam
e
Inj Nam e RT Area U SPResolution U SPTailing U SPPlateCoun
t
1 STD1 1 ISONIAZI 2 .660 1518803 1.469 7755
Mean 1518803
%RSD
Table no.5                               Data for system suitability of RIFAMPICIN
Name: RIFAMPICIN
SampleNa m Inj Nam e RT Area U SPReso lutio U SPTailing U SPPlateCount
1 STD1 1 RIFAMPICI 3 .172 2348101 31.412 7613
Mean 2348101
%RSD
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Fig no.3Chromatogram of standard 1
Table no.4                               Data for system suitability of ISONIAZID
Name: ISONIAZID 
SampleName Inj Nam e RT Area U SPReso lution U SPTailing U SPPlateCount
1 STD1 1 ISONIAZID2.660 1518803 1.469 7755
Mean 1518803
%RSD
Table no.5                               Data for system suitability of RIFAMPICIN
Name: RIFAMPICIN
SampleName Inj Nam e RT Area U SPReso lution USPTailing USPPlateCount
1 STD1 1 RIFAMPICIN3.172 2348101 31.412 7613
Mean 2348101
%RSD
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Fig no.4Chromatograms of standard 2
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Table no.6                                Results of system suitability (ISONIAZID)
Name: ISONIAZID
Table no.7                              Results of system suitability (RIFAMPICIN)
Sample
Name
Inj Nam e RT Area U SPReso lution U SPTailing U SPPlateCo unt
1 STD2 1 RIFAMPICI
N
3.170 2518297 3
4
1.420 7539
2 STD2 2 RIFAMPICI
N
3.172 2514902 3
9
1.407 7382
3 STD2 3 RIFAMPICI
N
3.173 2535682 3
3
1.402 7460
4 STD2 4 RIFAMPICI
N
3.170 2520334 3
1
1.428 7586
5 STD2 5 RIFAMPICI
N
3.174 2528250 3
0
1.390 7441
Mean 2523493
%RSD
     0 .3
Name: RIFAMPICI
SPECIFICITY
Specificity is the ability to assess unequivocally of an analyte in the presence of components
which may be expected to be present. Lack of specificity of an individual analytical procedure may
be compensated by other supporting analytical procedures.
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Sample
Name
Inj Nam e RT Area USPReso lutio
n
USP Tailing U SPPlateCo unt
1 STD2  1 ISONIAZI 2 .663 151632  1.436 7479
2 STD2  2 ISONIAZI 2 .666 150283  1.426 7316
3 STD2  3 ISONIAZI 2 .668 151642  1.428 7288
4 STD2  4 ISONIAZI 2 .667 150767  1.424 7576
5 STD2  5 ISONIAZI 2 .672 152012  1.448 7392
Mean 151267
%RSD
      0 .5
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Blank,  standard,  placebo,  all  known  related  compounds,  spiked  sample,  sample
solutions  were  prepared  and  injected  into  the  chromatographic  system  for  identification  and
interference with the Isoniazid and Rifampicin peaks. 
Placebo Interference:
A study to establish the interference of placebo was conducted. Sample preparation of placebo was
done as that of test sample preparation of assay method. Chromatogram of placebo did not show
any additional peaks. This indicated that the excipients used in the formulation did not interfere in
the assay of Isoniazid and Rifampicin tablets. Resulted chromatograms were shown below. 
Blank Interference:
A study to establish the interference of blank was conducted. Mobile phase was injected as per the
test method and are shown below.
Fig no.5
Table no.8                              Component Summary Table for ISONIAZID
Department of Pharmaceutical analysis, K.M college of pharmacy, Madurai. Page 47
                                                                                                                                                     Method Validation
Sample Name Inj Name RT Are
a
1 Blank 1 ISONIAZI
D
2.600
2 Placebo 1 ISONIAZI
D
2.600
Table no.9                            Component Summary Table for RIFAMPICIN
Sample Name Inj Name RT Area
1 Blank 1 RIFAMPICIN 3.100
2 Placebo 1 RIFAMPICIN 3.100
Precision: 
Precision is the measure of the degree of repeatability of analytical method under normal
operation and is normally expressed as %RSD for the statistically significant number of samples.
Method Precision:
Six  sample  preparations  were  prepared  individually  using  single  batch  of  Isoniazid  and
Rifampicin tablets (1/32 mg) as per test method and injected each solution. Resulted chromatogram
was shown in the fig. no. 6. And data was shown in below table10.
Fig no.6Chromatograms for sample
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Table no.10                             Data for system suitability (ISONIAZID)
Name: ISONIAZID
SampleNam e Inj Nam e RT Area
1 PRECISION1 1 ISONIAZID 2.671 1519920
2 PRECISION2 1 ISONIAZID 2.673 1516120
3 PRECISION3 1 ISONIAZID 2.676 1511693
4 PRECISION4 1 ISONIAZID 2.683 1518392
5 PRECISION5 1 ISONIAZID 2.684 1514151
6 PRECISION6 1 ISONIAZID 2.683 1511595
Table no.11                           Data for system suitability (RIFAMPICIN)
Name: RIFAMPICIN
SampleNam e Inj Nam e RT Area
1 PRECISION1 1 RIFAMPICIN 3.172 2525898
2 PRECISION2 1 RIFAMPICIN 3.173 2527812
3 PRECISION3 1 RIFAMPICIN 3.175 2527001
4 PRECISION4 1 RIFAMPICIN 3.184 2529333
5 PRECISION5 1 RIFAMPICIN 3.182 2520997
6 PRECISION6 1 RIFAMPICIN 3.177 2521813
Table no.12                Calculated data for repeatability of Isoniazid and Rifampicin
Department of Pharmaceutical analysis, K.M college of pharmacy, Madurai. Page 50
                                                                                                                                                     Method Validation
S.No
Sample
Weigh
t
Sample
Area-1
Sample
Area-
2
%
Ass
ay
% Assay
1 902.55 1519920 2525898 100 100
2 902.55 1516120 2527812 99 100
3 902.55 1511693 2527001 99 100
4 902.55     1518392 2529333 99 100
5 902.55 1514151 2520997 99 100
6 902.55 1511592 2521813 99 100
Average
Assay
99 100
STD 0.23 0.13
%RSD 0.23 0.13
Acceptance criteria:
The % RSD of individual Isoniazid and Rifampicintablet from the six units should be not
more than 2.0%.
All assay values should be within the 90.0 % - 110.0 % of label claim.
LINEARITY AND RANGE
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Linearity
Linearity of an analytical procedure is its ability (within a given range) to obtain test results
which are directly proportional to the concentration (amount) of an analyte in the sample.
Range
Range  of  an  analytical  procedure  was  the  interval  between  the  upper  and  lower
concentration (amount) of an analyte in the sample (including these concentrations) for which it
has been demonstrated that the analytical procedure has suitable level of precision, accuracy and
linearity.
Standard solutions of Isoniazid and Rifampicin at concentration levels from 50 % to 150 %
of standard solution were injected into HPLC system. The linearity graph was plotted from 50 % to
150 
Acceptance criteria
a. The correlation coefficient (r2) must be NLT 0.999.
b. The RSD of replicate injections for lower and upper level  concentrations should not be
more than2.0 %. 
Fig no.7Chromatograms for linearity
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Table no.13                             Data for system suitability (ISONIAZID)
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Name: ISONIAZID
SampleNam e Inj Nam e RT Area
1 LINEARITY-50% 1 ISONIAZID 2.718 756326
2 LINEARITY-75% 1 ISONIAZID 2.724 1136736
3 LINEARITY-100% 1 ISONIAZID 2.726 1518154
4 LINEARITY-125% 1 ISONIAZID 2.728 1895086
5 LINEARITY-150% 1 ISONIAZID 2.728 2266725
Fig no.8             Calibration curve for Isoniazid
Table no.14                           Calculated data for linearity (ISONIAZID)
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Table no.15                          Data for system suitability (RIFAMPICIN)
Name: RIFAMPICIN
SampleNam e Inj Nam e RT Area
1 LINEARITY-50% 1 RIFAMPICIN 3.188 1260352
2 LINEARITY-75% 1 RIFAMPICIN 3.192 1897143
3 LINEARITY-100% 1 RIFAMPICIN 3.193 2525789
4 LINEARITY-125% 1 RIFAMPICIN 3.195 3154260
5 LINEARITY-150% 1 RIFAMPICIN 3.189 3784968
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ISONIAZID
Conc% Area Concentration (µg/ml)
50 756326 600
75 1136736                900.00
100 1518154                1200.00
125 1895086    1500
150 2266725    1800
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Fig no.9         Calibration curve for Rifampicin
Table no.16                    Calculated data for linearity (RIFAMPICIN)
METHOD ACCURACY
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RIFAMPICIN
Conc% Area Concentration (µg/ml)
50 1260352 900
75 1897143 1350
100 2525789 1800
125 3154260 2250
150 3784968 2700.00
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The accuracy of an analytical procedure expresses the closeness of agreement between the
values which is accepted either as a conventional true value or an accepted reference value for the
observed value.
Fig no.10 Chromatograms for sample of 50% concentration
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Table no.17                            Data for accuracy of 50% concentration of Isoniazid 
Name: ISONIAZID
SampleNam e Inj Nam e RT Area
1 ACCURACY-50%-1 1 ISONIAZID 2.688 756728
2 ACCURACY-50%-2 1 ISONIAZID 2.687 756907
3 ACCURACY-50%-3 1 ISONIAZID 2.687 756975
4 ACCURACY-50%-4 1 ISONIAZID 2.696 756326
5 ACCURACY-50%-5 1 ISONIAZID 2.699 756274
6 ACCURACY-50%-6 1 ISONIAZID 2.695 756141
Table no.18                     Data for accuracy of 50% concentration of Rifampicin 
Name: RIFAMPICIN
SampleNam e Inj Nam e RT Area
1 ACCURACY-50%-1 1 RIFAMPICIN 3.183 1265170
2 ACCURACY-50%-2 1 RIFAMPICIN 3.180 1262461
3 ACCURACY-50%-3 1 RIFAMPICIN 3.178 1261719
4 ACCURACY-50%-4 1 RIFAMPICIN 3.187 1263056
5 ACCURACY-50%-5 1 RIFAMPICIN 3.187 1268196
6 ACCURACY-50%-6 1 RIFAMPICIN 3.182 1262096
Fig no.11Chromatograms for sample of 100% concentration
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Table no.19                      Data for accuracy of 100% concentration of Isoniazid
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Name: ISONIAZID
Sample Name Inj Name RT Area
1 ACCURACY – 100% -1 1 ISONIAZID 2.695 1512475
2 ACCURACY – 100% -2 1 ISONIAZID 2.696 1518251
3 ACCURACY – 100% -3 1 ISONIAZID 2.699 1512296
Table no.20                        Data for accuracy of 100% concentration of Rifampicin
Name: RIFAMPICIN
Sample Name Inj Name RT Area
1 ACCURACY – 100% -1 1 RIFAMPICIN 3.178 2523741
2 ACCURACY – 100% -2 1 RIFAMPICIN 3.179 2525279
3 ACCURACY – 100% -3 1 RIFAMPICIN 3.179 2528251
Fig no.12 Chromatograms for sample of 150% concentration
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Table no.21                           Data for accuracy of 150% concentration of Isoniazid
Name: ISONIAZID
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SampleNam e Inj Nam e RT Area
1 ACCURACY-150%-1 1 ISONIAZID 2.701 2260654
2 ACCURACY-150%-2 1 ISONIAZID 2.705 2262479
3 ACCURACY-150%-3 1 ISONIAZID 2.709 2260325
4 ACCURACY-150%-4 1 ISONIAZID 2.714 2262513
5 ACCURACY-150%-5 1 ISONIAZID 2.721 2263234
6 ACCURACY-150%-6 1 ISONIAZID 2.713 2266385
Table no.22                      Data for accuracy of 150% concentration of Rifampicin
Name: RIFAMPICIN
SampleNam e Inj Nam e RT Area
1 ACCU RACY-150%-1 1 ISONIAZID 2.701 2260654
2 ACCU RACY-150%-2 1 ISONIAZID 2.705 2262479
3 ACCU RACY-150%-3 1 ISONIAZID 2.709 2260325
4 ACCU RACY-150%-4 1 ISONIAZID 2.714 2262513
5 ACCU RACY-150%-5 1 ISONIAZID 2.721 2263234
6 ACCU RACY-150%-6 1 ISONIAZID 2.713 2266385
Table no.23                          Results of Accuracy study (ISONIAZID)
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Table no.24                Results of Accuracy study (RIFAMPICIN)
RIFAMPICIN
Sample
Area
µg/ml
added
µg/ml
found
%
Recove
ry
     %
Mean 
1265170 891.010 899.73 101
101
1262461 891.010 897.81 101
1261719 891.010 897.28 101
1263056 891.010 898.23 101
1268196 891.010 901.89 101
1262096 891.010 897.55 101
2523741.0
0
1782.000    1795.78 101
101
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2525279.0
0
1782.000 1795.87 101
2528251.0
0
1782.000 1797.98 101
3782160 2673.010 2689.71 101
101
3785672 2673.010 2692.21 101
  3782793 2673.010 269016 101
3785575 2673.010 2692.14 101
3788145 2673.010 2693.97 101
3789803 2673.010 2695.15 101
ROBUSTNESS
The robustness is a measure of method capacity to remain unaffected by small, deliberate
variations  in method parameters and provides an indication of method reliability during normal
use.
Standard was prepared and injected into the chromatographic system as per the conditions
specified in the method.
The  same  standard  was  reinjected  by  altering  one  parameter  at  a  time,  keeping  other
parameters constant.
A set of system suitability data was calculated for standards injected under altered method
conditions and compared against the values generated under normal method conditions. The results
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were tabulated in below table. 
Acceptance Criteria
All the system suitability requirements must be met.
Method Parameters: 
1. Flow Rate 
    (Normal flow is 1.0 ml/min)
a. Reduced flow  ®  0.9 ml/min
b. Increased flow ®1.1 ml/min
2. Column Operating Temperature 
    (Normal temperature is 30 °C)
a. Reduced Temperature  ®   25 °C
b. Elevated Temperature  ®   35 °C
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Fig no.1 Chromatograms for sample flow and temperature
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Table no.25         Data for variation in temperature and flow rate (ISONIAZID)
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SampleName Inj Nam e RT Area USPResolution U SPTailing USPPlateCount
1 FLOW1 1 ISONIAZID 2.673 14574 1 .421 7399
2 FLOW2 1 ISONIAZID 2.675 15782 1 .398 7247
3 TEMP1 1 ISONIAZID 2.677 15164 1 .393 7510
4 TEMP2 1 ISONIAZID 2.685 15232 1 .411 7515
Table no.26          Data for variation in temperature and flow rate (RIFAMPICIN)
SampleNa me Inj Nam e RT Area U SPResolution U SPTailing U SPPlateCount
1 FLOW1 1 RIFAMPICIN3.173 2748228 3
96
1.378 7386
2 FLOW2 1 RIFAMPICIN3.173 2352295 3
78
1.410 7350
3 TEMP1 1 RIFAMPICIN3.177 2544191 3
90
1.374 7233
4 TEMP2 1 RIFAMPICIN3.186 2551703 3
01
1.364 7300
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RESULTS AND DISCUSSION
Analytical method development and method validation was performed for RP-HPLC
method for  the Isoniazid and Rifampicin in tablet  formulation as  per  ICH norms for the
following parameters: system suitability, linearity and precision (repeatability), intermediate
precision  (ruggedness),  specificity  and  accuracy.  The  summary  of  results  obtained  in
analytical method development and validation were tabulated in table no.26.
VALIDATION SUMMARY REPORT
The  observations  and  results  obtained  for  each  of  the  parameters  like  system
suitability, linearity, precision (repeatability), specificity, accuracy and robustness lies well
within the acceptance criteria. So the developed method was simple, specific, linear, precise,
and accurate and robustness could be extensively used for the Isoniazid and Rifampicin in
tablet formulation system.
Table no. 26Validation parameters and acceptance criteria for INH and RIF
S.
No
Validation parameters Specification Results
1
System suitability Isoniazid Rifampicin
Retention time Not applicable 2.660 3.172
Tailing NMT 2 1.469 1.412
Resolution NLT 2 3.697
Theoretical plates NLT 2500 7755 7613
Similarity factor 0-98 to 1.02 0.99 0.99
%RSD NMT 2.0% 0.5 0.3
2 Specificity
There is no peak in blank at the Rt
of analyte Nil Nil
There is no peak in placebo at the
Rt of analyte Nil Nil
3 Precision
The value should be between 97%
to 103%
100 100
99 100
99 100
99 100
99 100
99 100
The %RSD of six replicate assay
results NMT 2.0%
0.23 0.13
4 Accuracy (50%) The value should be between 97%
to 103%
100
101
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Accuracy (100%)
The value should be between 97%
to 103%
100 101
Accuracy (150%)
The value should be between 97%
to 103%
100 101
5 Linearity Correlation coefficient NLT 0.999 0.998 0.997
6 LOD Not applicable 2.88 µg/ml 2.77 µg/ml
7 LOQ Not applicable 9.58 µg/ml 9.22 µg/ml
8 Range Not applicable
600µg to
1800 µg/ml
900µg to
2700 µg/ml
9
Robustness(Flow-1)
Tailing NMT 2 1.421 1.378
Resolution NMT 2 Nil 3.596
Theoretical plates NLT 2500 7399 7386
Robustness(Flow-2)
Tailing NMT 2 1.398 1.410
Resolution NMT 2 Nil 3.578
Theoretical plates NLT 2500 7247 7350
Robustness(Temp-1)
Tailing NMT 2 1.393 1.374
Resolution NMT 2 Nil 3.590
Theoretical plates NLT 2500 7510 7233
Robustness(Temp-2)
Tailing NMT 2 1.411 1.364
Resolution NMT 2 Nil 3.601
Theoretical plates NLT 2500 7515 7300
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CONCLUSION
From the results obtained, it was observed that the developed method was proven to
be  specific,  precise,  linear,  accurate,  rugged  and  robust  and  is  suitable  for  its  intended
purpose. So the above work performed gives documented evidence that the analytical method
for  the  Isoniazid  and  Rifampicin  by  RP-HPLC  in  tablet  dosage  forms  will  consistently
analyze these drugs quantitatively and could be used for routine analysis.
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ABBREVATIONS
API - Active pharmaceutical ingredient
MeOH - Methanol
ACN - Acetonitrile
RT - Retention time
RH - Relative Humidity
CI - Confidence interval
NMT - Not more than
NLT - Not less than
NA - Not applicable
ND - Not detected
Fig - Figure
PDA - Photo diode array
PKa _ Acid dissociation constant
K - Partition coefficient
%RSD - %Relative standard deviation
RPM - Revolutions per minute
ODS - Octa decyl silane
K' - Capacity factor
N - Theoretical plate number/efficiency
LOD - Limit of detection
LOQ - Limit of quantitation
ICH - International Conference on Hormonization
Conc - Concentration
Std - Standard
ppm - Parts per million
ppb - Parts per billion
DS - Drug substance
DP - Drug product
µL - Micro liter
µg - Micro gram
λ - Lambda
µ - Micron
mL - Milli liter
mg - Milli gram
nm - Nanometer
Max - Maximum
S.no - Serial number
oC - Degree celsius
pH - Hydrogen ion concentration
HPLC -  High performance liquid chromatography
UV - Ultraviolet-Visible
